Female Pattern Hair Loss (FPHL)
FPHL is the most common form of female hair loss.
It is a form of androgenetic alopecia. It will affect 40% of all women at some point in their lives. It can affect women before and after menopause.
Pre-menopausal FPHL is more dependent on circulating and tissue androgen concentrations.
Post menopausal FPHL is less dependent on concentration of circulating and tissue androgens. It is dependent on many factors.
Treatment strategies for Pre-menopausal FPHL causes differ from Post-menopausal FPHL . As a result treatment strategies proposed by your Hair Loss Specialist will differ for both types of FPHL.
Treatment of FPHL
Although FPHL is a condition that does not compromise physical health women are naturally psychologically distressed by the cosmetic outcome of hair loss. With appropriate diagnosis and treatment hair loss can be reduced and new hair growth triggered by use of appropriate therapies such as:
- Oral and topical low dose minoxidil
- Intradermal Dutasteride injections
- Platelet Rich Plasma Therapy (PRP injection)
It is important that women of child bearing age should not become pregnant whilst on certain treatment regimens. Drugs such as finasteride and dutasteride must not be used if considering pregnancy. Adequate contraception should be used whilst on these medications.
Why is our approach different or better?
- The approach of treatment is highly focused on correct diagnosis and finding any triggering factors or accelerators, using methods like trichoscopy, visual examination, blood tests and biopsy.
- Compliance is another biggest focus when we treat FPHL. Since it is genetic condition that requires ongoing maintenance, the compliance and convenience of the treatment regimen are highly.
- All the medications are individually made to tailor the need of each patient to maximise the efficacy and to minimise side-effects.